Welcome to AstraZeneca United States
We push the boundaries of science to deliver life-changing medicines
Latest News from AstraZeneca US
BYDUREON BCise (exenatide extended-release) approved in the US for the treatment of type 2 diabetes in pediatric patients ages 10 years and older
Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma
Phase III pivotal trial of once weekly exenatide in adolescents aged 10–17 shows benefit for the treatment of type 2 diabetes
CALQUENCE demonstrated fewer incidences of atrial fibrillation versus ibrutinib in previously treated patients with chronic lymphocytic leukemia and sustained patient benefit at four years in the front-line setting
We want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening conditions, achieve remission, and one day cure them.
We are leading a revolution in oncology to redefine cancer care. We have a bold ambition to provide cures for cancer in every form. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save the lives of people around the world.
If you are passionate about science, these stories will show you how the latest and most exciting projects we have been working on and the people behind them.